Results vary depending on several factors, including: starting body weight dosage consistency nutrition habits sleep activity level underlying metabolic health Some people notice gradual, steady fat loss, while others experience more dramatic changes after dosage increases
How does the dosing of GLP-1/GIP medications change with their intended disease target
He also highlights the importance of addressing underlying health factors like immune dysfunction, toxin buildup, and co-infections like Bartonella and mold toxicity in chronic Lyme patients
Although the underlying contributors to these differences cannot be determined from observational data, potential factors may include variation in baseline clinical characteristics, access to care, treatment persistence, dose escalation, social determinants of health, and unmeasured biological heterogeneity
This may help provide context for clinical conversations about expected response patterns, though genetic predisposition does not guarantee exact medication outcomes
